ED
Eric M Dube (CHIEF EXECUTIVE OFFICER) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $25.4M of TVTX (399,730 sh across 7 lots, as filed), executed Sep 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$50.8M
shares × price, as filed
Last traded
Oct 15
Filed Oct 19
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $56.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$13.1M243,735 sh across 3 lots
Exec Oct 15
Filed Oct 19 · 4:05 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $25.4M
399,730 sh across 7 lots
Exec Sep 15
Filed Sep 17 · 9:31 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $989K
22,500 sh × $43.95
Exec May 6
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $2.6M
63,980 sh across 2 lots
Exec Apr 15
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.9M
60,000 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.8M
60,000 sh × $30.10
Exec Feb 20
Filed Feb 24 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $3.2M
100,087 sh across 2 lots
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.8M
60,000 sh across 2 lots
Exec Jan 23
Filed Jan 27 · 5:30 PM ET More filings →